The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
Crossref DOI link: https://doi.org/10.1186/s13023-014-0120-x
Published Online: 2014-08-05
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kreeftmeijer-Vegter, Annemarie Rosan
de Boer, Anthonius
van der Vlugt-Meijer, Roselinda H
de Vries, Peter J
License valid from 2014-08-05